Controlling BCG Vaccine’s Cell Viability in the Process of Its Production by an Bioluminescent ATP Assay
- 1 July 2019
- journal article
- research article
- Published by Allerton Press in Moscow University Chemistry Bulletin
- Vol. 74 (4) , 191-197
Abstract
The Bacille Calmette–Guerine (BCG) vaccine, which is based on a live strain of Mycobacterium bovisBCG is widely used for the immunoprophylaxis of tuberculosis. One of the BCG vaccine’s key...Keywords
This publication has 12 references indexed in Scilit:
- Bacillus Calmette-Guérin (BCG) vaccine: A global assessment of demand and supply balanceVaccine, 2018
- A simplified ATP method for the rapid control of cell viability in a freeze-dried BCG vaccineJournal of Microbiological Methods, 2016
- Bioluminescence assay for cell viabilityBiochemistry (Moscow), 2015
- Quality control and safety assessment of BCG vaccines in the post-genomic eraBiotechnology & Biotechnological Equipment, 2014
- Characterization of an intracellular ATP assay for evaluating the viability of live attenuated mycobacterial vaccine preparationsJournal of Microbiological Methods, 2012
- Thermostabilization of firefly luciferase by in vivo directed evolutionProtein Engineering, Design and Selection, 2011
- Development and validation of an ATP method for rapid estimation of viable units in lyophilised BCG Danish 1331 vaccineBiologicals, 2008
- Report of an international collaborative study to establish the suitability of using modified ATP assay for viable count of BCG vaccineVaccine, 2008
- Report on a WHO consultation on the characterisation of BCG vaccines, WHO, Geneva, Switzerland 8–9 Dec 2004Vaccine, 2005
- Use of firefly luciferase in atp-related assays of biomass, enzymes, and metabolites2000